MYD88 and metabolic dysfunction-associated steatotic liver disease: MyD88 in myofibroblasts promotes fat accumulation by enhancing lipid droplet accumulation in HSCs and promotes macrophage M2 polarization and enhances NAFLD to HCC progression by secreting CCL9/CCL15.